Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:1141-1146

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, S.
Right arrow Articles by Sudhir, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ling, S.
Right arrow Articles by Sudhir, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Gene expression
Right arrow Growth factors/cytokines

(Hypertension. 1999;34:1141-1146.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Matrix-Dependent Gene Expression of Egr-1 and PDGF A Regulate Angiotensin II–Induced Proliferation in Human Vascular Smooth Muscle Cells

Shanhong Ling; Aozhi Dai; Yunn-Hwa Ma; Emily Wilson; Kanu Chatterjee; Harlan E. Ives; Krishnankutty Sudhir

From the Divisions of Nephrology and Cardiology, Cardiovascular Research Institute, University of California (Y-H.M., E.W., K.S., H.E.I.), San Francisco; and the Hormones and Vasculature Laboratory, Baker Medical Research Institute and Alfred and Baker Medical Unit, Alfred Hospital (S.L., A.D., K.S.), Melbourne, Australia.

Correspondence to K. Sudhir, MD, PhD, Alfred and Baker Medical Unit, 3rd Floor, Alfred Hospital, Commercial Road, Prahran, VIC 3181, Australia. E-mail: krishna.sudhir{at}baker.edu.au

Abstract—We have previously shown, in a neonatal rat cell line, that angiotensin II (Ang II)–induced proliferation in vascular smooth muscle cells is extracellular matrix (ECM) dependent. We hypothesized that such an effect might be mediated via differences in Ang II–induced increases in the transcriptional factor early growth response-1 (Egr-1) gene and, consequently, in platelet-derived growth factor (PDGF). Cultured human newborn aortic smooth muscle cells were studied on 4 different surfaces: (1) plastic, (2) laminin, (3) collagen, and (4) fibronectin. Ang II–induced increases in DNA synthesis were significantly greater on collagen (2.0±0.3-fold) and fibronectin (1.9±0.3-fold) than on laminin (1.0±0.2-fold) or plastic (1.4±0.2-fold). As with DNA synthesis, at 48 and 72 hours, Ang II–induced increases in cell numbers occurred only in cells grown on collagen and fibronectin culture plates and were blocked by an antagonist to the angiotensin type 1 (losartan, 10 µmol/L) but not the angiotensin type 2 (PD 123319, 10 µmol/L) receptor. Anti-PDGF AA antibody (6 µg/mL) blocked the increase in DNA synthesis by 60% to 64% in cells on collagen or fibronectin cultures but not on plastic cultures. When PDGF-AA (10 ng/mL) and Ang II were added together, DNA synthesis increased 2-fold and did not differ on the various ECM proteins. Increases in PDGF A-chain mRNA were observed only in cells grown on collagen (3.21±0.65-fold) and fibronectin (2.86±0.49-fold) plates 2 to 8 hours after the addition of Ang II and were blocked by losartan but not PD 123319. Expression of Egr-1, an early growth response gene, increased at 15 minutes, peaked at 30 minutes, and returned to normal after 2 hours with Ang II treatment. Ang II–induced increases in Egr-1 mRNA were greater on collagen (4.82±0.66-fold at maximum) and fibronectin (4.01±0.56-fold) than on laminin (2.74±0.45-fold) or plastic (2.53±0.40-fold) and were blocked by losartan but not PD 123319. Thus, in human vascular smooth muscle cells in culture, Ang II–induced proliferation is mediated via the angiotensin type 1 receptor, dependent on ECM proteins, and regulated by differential gene expression of Egr-1 and PDGF-1.


Key Words: angiotensin II • matrix • early growth response-1 gene • platelet-derived growth factor




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
T. A. Morinelli, J. R. Raymond, A. Baldys, Q. Yang, M.-h. Lee, L. Luttrell, and M. E. Ullian
Identification of a putative nuclear localization sequence within ANG II AT1A receptor associated with nuclear activation
Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1398 - C1408.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Thengchaisri, T. W. Hein, W. Wang, X. Xu, Z. Li, T. W. Fossum, and L. Kuo
Upregulation of Arginase by H2O2 Impairs Endothelium-Dependent Nitric Oxide-Mediated Dilation of Coronary Arterioles
Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2035 - 2042.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. D Hughes
AT 1-signalling in vascular smooth muscle
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 125 - 130.
[PDF]